Abbott Laboratories (ABT) vs GE HealthCare Technologies Inc. (GEHC)
Abbott Laboratories and GE HealthCare Technologies Inc. are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $174.8B against $29.9B — 5.9× the size. GE HealthCare Technologies Inc. trades at the lower P/E: 15.3× against 32.8×. Abbott Laboratories grew revenue faster over the last twelve months: 8.06% against 6.51%. Abbott Laboratories has the higher net margin (11.7% vs 9.33%) and the lower return on invested capital (5.83% vs 8.37%). Both pay a dividend; Abbott Laboratories yields more (1.88% vs 0.13%). Across the 23 metrics below, Abbott Laboratories leads on 12 and GE HealthCare Technologies Inc. on 11.
Valuation
Profitability
| Metric | ABT | GEHC | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 39.54% | 56.01% |
| Operating margin | 15.77% | 12.86% | (15.03%) |
| Net margin | 11.65% | 9.33% | (20.40%) |
| Free cash flow margin | 16.80% | 7.42% | (7.24%) |
| Return on equity | 10.58% | 19.15% | (15.32%) |
| Return on assets | 5.62% | 5.45% | (19.72%) |
| Return on invested capital | 5.83% | 8.37% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack